Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-21 3:49 pm Purchase | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 20,174 9.970% | 9,484 (+88.71%) | Filing History |
| 2022-01-20 4:23 pm Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Rosalind Advisors, Inc. | 96,948 6.500% | 15,693 (+19.31%) | Filing History |
| 2022-01-20 4:21 pm Purchase | 2021-12-31 | 13G | Myomo, Inc. MYO | Rosalind Advisors, Inc. | 553,290 8.100% | 187,390 (+51.21%) | Filing History |
| 2022-01-06 8:15 pm Purchase | 2022-01-06 | 13G | Astria Therapeutics, Inc. ATXS | Rosalind Advisors, Inc. | 653,438 5.000% | 653,438 (New Position) | Filing History |
| 2021-09-23 4:54 pm Purchase | 2021-09-14 | 13G | Unicycive Therapeutics, Inc. UNCY | Rosalind Advisors, Inc. | 81,256 5.600% | 81,256 (New Position) | Filing History |
| 2021-07-08 1:30 pm Purchase | 2021-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 10,691 6.000% | 10,691 (New Position) | Filing History |
| 2021-06-25 5:20 pm Sale | 2021-06-23 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors, Inc. | 1,253,958 9.900% | -713,542 (-36.27%) | Filing History |
| 2021-05-19 2:25 pm Purchase | 2021-05-12 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Rosalind Advisors, Inc. | 2,607,857 5.400% | 2,607,857 (New Position) | Filing History |
| 2021-05-19 1:37 pm Purchase | 2021-05-05 | 13G | Myomo, Inc. MYO | Rosalind Advisors, Inc. | 365,900 6.500% | 365,900 (New Position) | Filing History |
| 2021-04-06 10:01 am Unchanged | 2021-03-31 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors, Inc. | 1,967,500 9.900% | 0 (Unchanged) | Filing History |
| 2021-01-22 5:26 pm Purchase | 2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Rosalind Advisors, Inc. | 179,237 4.800% | 45,904 (+34.43%) | Filing History |
| 2021-01-22 5:26 pm Unchanged | 2020-12-31 | 13G | PLX PHARMA INC PLXPQ | Rosalind Advisors, Inc. | 970,425 6.700% | 0 (Unchanged) | Filing History |